Pediatric dermatoses: Off-label biologic use carries risks, benefits
April 1st 2010Psoriasis in adults is among the most-researched inflammatory skin diseases. Yet treatment options for moderate-to-severe atopic dermatitis and psoriasis in children represents a largely unmet medical need, according to an expert.
Woundcare systems: Integrated approach provides uniform evidenced-based care
December 1st 2008An integrated approach to woundcare yields improved outcomes for patients, according to recent research. Over the past five years, numerous organizations have come up with guidelines for integrated woundcare systems, an expert says.
Understanding the benefits of p16 testing for high-risk familial melanoma patients
January 1st 2008P16-mutation carriers are at extremely high risk for developing melanoma. Many high-risk melanoma clinics worldwide are reporting genetic test results, and clinical testing also is increasing in the United States. There are currently no guidelines regulating genetic testing in the United States, but melanoma genetics experts are working to develop meaningful guidelines that will, hopefully, be published in early 2008.